FDA Approved: TECFIDERA — Supplemental Application (Biogen Inc.)

View source ↗

Summary

FDA approved a supplemental application for TECFIDERA (dimethyl fumarate) submitted by Biogen Inc., resulting in changes to the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tecfidera (dimethyl fumarate)

Snippet

SUPPL AP for TECFIDERA (DIMETHYL FUMARATE)